2024-10-18 20:24:59
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1)
Health/ 2023-07-22
New Early Breast Cancer Drug to Reduce R...

NERLYNX® (neratinib) now approved by the Therapeutic Goods Administration for Australian women2 Leading Australian breast cancer oncolog...

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.
Corporate/ 2023-07-23
Innovent Announces First Patient Dosed i...

SUZHOU,China,March19,2019--Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that develops and commer...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release